CBD of Denver, Inc.
corporate_fare Company Profile
CBD of Denver, Inc. (OTC:CBDD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CBDD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above.
Recent high-impact activity:
- CBD of Denver Signs Definitive Share Exchange Agreement with BioCannabis M. IKE
- CBD of Denver Enters Due Diligence for AI-Driven Health & Wellness Acquisition
- CBD of Denver Pivots to AI, Actively Seeks Merger Candidates in High-Growth Productivity Sector
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 392,750 shares in CBDD as of the September 15, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 73.4% of CBDD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.